Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000990901 | SCV001141954 | pathogenic | Developmental and epileptic encephalopathy, 9 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001266326 | SCV001444500 | pathogenic | Inborn genetic diseases | 2019-06-20 | criteria provided, single submitter | clinical testing | |
Centre de Biologie Pathologie Génétique, |
RCV000990901 | SCV002558965 | pathogenic | Developmental and epileptic encephalopathy, 9 | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000990901 | SCV004300137 | pathogenic | Developmental and epileptic encephalopathy, 9 | 2023-12-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile781Asnfs*3) in the PCDH19 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PCDH19 are known to be pathogenic (PMID: 21053371). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with PCDH19-related conditions (PMID: 22946748, 32852734). ClinVar contains an entry for this variant (Variation ID: 804051). For these reasons, this variant has been classified as Pathogenic. |